Search / Trial NCT06614114

Albumin Bilirubin Index as a Predictor of Outcome of Variceal Bleeding

Launched by ASSIUT UNIVERSITY · Sep 24, 2024

Trial Information

Current as of October 03, 2024

Recruiting

Keywords

Description

This study is to clarify the predictive value of albumin bilirubin index for recurrent bleeding within 3 month after endoscopic treatment in patients with cirrhosis and EGVB

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • * age between 18-80 years old
  • Exclusion Criteria:
  • * Hcc Hematological disease

About Sponsor

The National Institute of Allergy and Infectious Diseases (NIAID, /ˈnaɪ.æd/) is one of the 27 institutes and centers that make up the National Institutes of Health (NIH), an agency of the United States Department of Health and Human Services (HHS). NIAID's mission is to conduct basic and applied research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.

Contacts

JC

Jennifer Cobb

Immunology at National Institute of Allergy and Infectious Diseases (NIAID)

Locations

Assiut, , Egypt

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0